Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment.
Ther Adv Endocrinol Metab. 2025; 16:20420188251328210.TA

Abstract

Cystic fibrosis-related bone disease (CFBD) is a common endocrinopathy in people living with cystic fibrosis (CF) that is complex and multifactorial in origin. People with CF experience high rates of progressive bone density loss and increased fracture risk. Focus on prevention and treatment of CFBD is of increasing importance in a now aging CF population. This review will discuss current practices in CFBD, gaps in knowledge, and potential future studies with the goal of advancing the clinical care of patients with CFBD.

Links

PMC Free PDF

Authors+Show Affiliations

Cobb C

Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Wu M

Division of Endocrinology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Tangpricha V

Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, 101 Woodruff Circle, WMRB 1301, Atlanta, GA 30322, USA. Department of Medicine, Atlanta VA Medical Center, Decatur, GA, USA.

Pub Type(s)

Journal Article

Review

Language

eng

PubMed ID

40183033

Citation

Cobb, Crystal, et al. "Cystic Fibrosis-related Bone Disease: an Update On Screening, Diagnosis, and Treatment." Therapeutic Advances in Endocrinology and Metabolism, vol. 16, 2025, p. 20420188251328210.

Cobb C, Wu M, Tangpricha V. Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment. Ther Adv Endocrinol Metab. 2025;16:20420188251328210.

Cobb, C., Wu, M., & Tangpricha, V. (2025). Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment. Therapeutic Advances in Endocrinology and Metabolism, 16, 20420188251328210. https://doi.org/10.1177/20420188251328210

Cobb C, Wu M, Tangpricha V. Cystic Fibrosis-related Bone Disease: an Update On Screening, Diagnosis, and Treatment. Ther Adv Endocrinol Metab. 2025;16:20420188251328210. PubMed PMID: 40183033.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment. AU - Cobb,Crystal, AU - Wu,Malinda, AU - Tangpricha,Vin, Y1 - 2025/04/02/ PY - 2024/10/31/received PY - 2025/02/28/accepted PY - 2025/4/4/medline PY - 2025/4/4/pubmed PY - 2025/4/4/entrez KW - aging in cystic fibrosis KW - cystic fibrosis KW - cystic fibrosis-related bone disease KW - early bone loss KW - fragility fracture KW - highly effective modulator therapy KW - premenopausal osteoporosis SP - 20420188251328210 EP - 20420188251328210 JF - Therapeutic advances in endocrinology and metabolism JO - Ther Adv Endocrinol Metab VL - 16 N2 - Cystic fibrosis-related bone disease (CFBD) is a common endocrinopathy in people living with cystic fibrosis (CF) that is complex and multifactorial in origin. People with CF experience high rates of progressive bone density loss and increased fracture risk. Focus on prevention and treatment of CFBD is of increasing importance in a now aging CF population. This review will discuss current practices in CFBD, gaps in knowledge, and potential future studies with the goal of advancing the clinical care of patients with CFBD. SN - 2042-0188 UR - https://www.unboundmedicine.com/medline/citation/40183033/full_citation DB - PRIME DP - Unbound Medicine ER -

Tags

Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment.Ther Adv Endocrinol Metab. 2025; 16:20420188251328210.TA